The future of pharmaceuticals: Artificial intelligence in drug discovery and development
Chen Fu,
No information about this author
Qi Chen
No information about this author
Journal of Pharmaceutical Analysis,
Journal Year:
2025,
Volume and Issue:
unknown, P. 101248 - 101248
Published: Feb. 1, 2025
Language: Английский
EnGCI: enhancing GPCR-compound interaction prediction via large molecular models and KAN network
BMC Biology,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: May 15, 2025
Abstract
Background
Identifying
GPCR-compound
interactions
(GCI)
plays
a
significant
role
in
drug
discovery
and
chemogenomics.
Machine
learning,
particularly
deep
has
become
increasingly
influential
this
domain.
Large
molecular
models,
due
to
their
ability
capture
detailed
structural
functional
information,
have
shown
promise
enhancing
the
predictive
accuracy
of
downstream
tasks.
Consequently,
exploring
performance
these
models
GCI
prediction,
as
well
evaluating
effectiveness
when
integrated
with
other
learning
emerged
compelling
research
area.
This
paper
aims
investigate
challenges.
Results
study
introduces
EnGCI,
novel
model
comprising
two
distinct
modules.
The
MSBM
integrates
graph
isomorphism
network
(GIN)
convolutional
neural
(CNN)
extract
features
from
GPCRs
compounds,
respectively.
These
are
then
processed
by
Kolmogorov-Arnold
(KAN)
for
decision-making.
LMMBM
utilizes
large-scale
pre-trained
compounds
GPCRs,
subsequently,
KAN
is
again
employed
Each
module
leverages
different
sources
multimodal
fusion
enhances
overall
interaction
prediction.
Evaluating
EnGCI
on
rigorously
curated
dataset,
we
achieved
an
AUC
approximately
0.89,
significantly
outperforming
current
state-of-the-art
benchmark
models.
Conclusions
complementary
modules:
one
that
learns
scratch
prediction
task,
another
extracts
using
large
After
further
processing
integration,
information
enable
more
profound
exploration
understanding
complex
relationships
between
compounds.
offers
robust
efficient
framework
capabilities
potential
contribute
GPCR
discovery.
Language: Английский
Advanced deep learning approaches enable high-throughput biological and biomedicine data analysis
Leyi Wei
No information about this author
Methods,
Journal Year:
2024,
Volume and Issue:
230, P. 116 - 118
Published: Aug. 22, 2024
Language: Английский
Drug–drug interaction extraction based on multimodal feature fusion by Transformer and BiGRU
Chang-Qing Yu,
No information about this author
Shanwen Zhang,
No information about this author
Xuqi Wang
No information about this author
et al.
Frontiers in Drug Discovery,
Journal Year:
2024,
Volume and Issue:
4
Published: Oct. 29, 2024
Understanding
drug–drug
interactions
(DDIs)
plays
a
vital
role
in
the
fields
of
drug
disease
treatment,
development,
preventing
medical
error,
and
controlling
health
care-costs.
Extracting
potential
from
biomedical
corpora
is
major
complement
existing
DDIs.
Most
DDI
extraction
(DDIE)
methods
do
not
consider
graph
structure
molecules,
which
can
improve
performance
DDIE.
Considering
different
advantages
bi-directional
gated
recurrent
units
(BiGRU),
Transformer,
attention
mechanisms
DDIE
tasks,
multimodal
feature
fusion
model
combining
BiGRU
Transformer
(BiGGT)
here
constructed
for
In
BiGGT,
vector
embeddings
corpora,
molecule
topology
graphs,
are
conducted
by
Word2vec,
Mol2vec,
GCN,
respectively.
multi-head
self-attention
(MHSA)
integrated
into
to
extract
local–global
contextual
features,
important
The
extensive
experiment
results
on
DDIExtraction
2013
shared
task
dataset
show
that
BiGGT-based
method
outperforms
state-of-the-art
approaches
with
precision
78.22%.
BiGGT
expands
application
deep
learning
field
Language: Английский